Goldsher Dorith, Amikam Shlomo, Boulos Monther, Suleiman Mahmoud, Shreiber Reuven, Eran Ayelet, Goldshmid Yuval, Mazbar Ramzi, Roguin Ariel
Department of Radiology, Rambam Medical Center, Haifa, Israel.
Isr Med Assoc J. 2006 Feb;8(2):91-4.
Magnetic resonance imaging is a diagnostic tool of growing importance. Since its introduction, certain medical implants, e.g., pacemakers, were considered an absolute contraindication, mainly due to the presence of ferromagnetic components and the potential for electromagnetic interference. Patients with such implants were therefore prevented from entering MRI systems and not studied by this modality. These devices are now smaller and have improved electromechanical interference protection. Recently in vitro and in vivo data showed that these devices may be scanned safely by MRI.
To report our initial experience with three patients with pacemakers who underwent cerebral MRI studies.
The study included patients with clear clinical indications for MRI examination and who had implanted devices shown to be safe by in vitro and in vivo animal testing. In each patient the pacemaker was programmed to pacing-off. During the scan, continuous electrocardiographic telemetry, breathing rate, pulse oximetry and symptoms were monitored. Specific absorption rate was limited to 4.0 W/kg for all sequences. Device parameters were assessed before, immediately after MRI, and 1 week later.
None of the patients was pacemaker dependent. During the MRI study, no device movement was felt by the patients and no episodes of inappropriate inhibition or rapid activation of pacing were observed. At device interrogation there were no significant differences in device parameters pre-, post-, and 1 week after MRI. Image quality was unremarkable in all imaging sequences used and was not influenced by the presence of the pacemaker.
Given appropriate precautions, MRI can be safely performed in patients with a selected permanent pacemaker. This may have significant implications for current MRI contraindications.
磁共振成像作为一种诊断工具,其重要性日益增加。自其问世以来,某些医疗植入物,如起搏器,被视为绝对禁忌,主要是由于存在铁磁性部件以及电磁干扰的可能性。因此,植入此类装置的患者被禁止进入MRI系统,无法接受这种检查方式。现在这些装置体积更小,并且改进了机电干扰防护。最近的体外和体内数据表明,这些装置可以通过MRI安全扫描。
报告我们对三名植入起搏器的患者进行脑部MRI检查的初步经验。
该研究纳入了有明确MRI检查临床指征且其植入装置经体外和体内动物试验证明安全的患者。在每位患者中,将起搏器程控为非起搏状态。扫描期间,监测连续心电图遥测、呼吸频率、脉搏血氧饱和度和症状。所有序列的比吸收率限制在4.0W/kg。在MRI检查前、检查后即刻以及1周后评估装置参数。
所有患者均非起搏器依赖型。在MRI检查期间,患者未感觉到装置移动,也未观察到不适当的抑制或起搏快速激活事件。在对装置进行问询时,MRI检查前、检查后即刻以及检查后1周的装置参数无显著差异。在所有使用的成像序列中,图像质量均无异常,且不受起搏器存在的影响。
采取适当的预防措施后,MRI可安全地应用于选定的永久性起搏器植入患者。这可能对当前的MRI禁忌证产生重大影响。